Brookline Capital Markets
Affiliates

Track Record

Transactions

The team has completed over 300 transactions and engagements for its clients — valued at over $35 billion — as Bookrunner, Co-Manager, Lead Placement Agent, Co-Placement Agent or Advisor.

Featured Transactions

  1. April 2025Alcyone TherapeuticsBrookline served as Exclusive Placement Agent for the Series F Convertible Preferred stock offering.
  2. September 2025Sale to BiogenBiogen acquired Alcyone Therapeutics in 2025. Brookline served as Alcyone's financial advisor.
  3. July 2026Neela TherapeuticsNeela Therapeutics was spun out of the acquisition and Brookline served as the Exclusive Placement Agent for a Convertible Note in 2026.

Selected Client Transactions

Transaction results

  • Wave Aerospace

    $3,100,000

    Series AExclusive Placement Agent

  • Ainos

    $4,750,000

    Secured Convertible Promissory NoteCo-Placement Agent

  • Tonix Pharmaceuticals

    $4,500,000

    Follow-OnCo-Placement Agent

  • Hepion Pharmaceuticals

    $5,000,000

    Registered DirectFinancial Advisor

  • Adial Pharmaceuticals

    Completed EngagementCapital Markets Advisor

  • 99 Acquisition Group

    $75,000,000

    IPOCo-Manager

  • Eyenovia

    $12,000,000

    Registered DirectCo-Placement Agent

  • Keen Vision Acquisition Corporation

    $149,500,000

    IPOJoint Bookrunner

  • Tonix Pharmaceuticals

    $7,000,000

    Follow-OnCo-Placement Agent

  • 9 Meters Biopharma

    Completed EngagementCapital Markets Advisor

  • Genelux Corporation

    $5,500,000

    PIPEFinancial Advisor

  • Bukit Jalil Global Acquisition 1 Ltd.

    $57,500,000

    IPOCo-Manager

  • Imunon

    Completed EngagementCapital Markets Advisor

  • Genelux Corporation

    $18,000,000

    PIPEFinancial Advisor

  • Biocept

    $5,000,000

    Follow-OnLead Manager

  • Better Therapeutics

    $6,500,000

    PIPECo-Placement Agent

  • Aquestive Therapeutics

    Completed EngagementCapital Markets Advisor

  • Apexigen

    $2,800,000

    PIPEExclusive Placement Agent

  • Genelux Corporation

    $15,918,000

    IPOJoint Bookrunner

  • CNS Pharmaceuticals

    $6,000,000

    Follow-OnCo-Placement Agent

  • X4 Pharmaceuticals

    $65,000,000

    Follow-OnFinancial Advisor

  • SAB Biotherapeutics

    $7,900,000

    PIPESole Placement Agent

  • IceCure Medical

    $14,500,000

    Follow-OnCo-Placement Agent

  • Outlook Therapeutics

    $31,800,000

    Unsecured Convertible Promissory NoteFinancial Advisor